Study Finds Elevated Risk of Joint Infection After Chemotherapy Following Joint Replacement Surgery
Recent study suggests that individuals who undergo joint replacement surgery and later receive cancer chemotherapy may have an elevated risk of joint infection. Dr. Janet Conway’s research highlights the importance of understanding factors contributing to postoperative infections and the need for further investigation to protect joint replacement patients. Stay informed and proactive to mitigate the risk of joint infections following chemotherapy post joint replacement surgery.
Zimmer Biomet Receives FDA Clearance for Rosa Robotic-Assisted Total Shoulder Replacement System
Zimmer Biomet has received FDA 510(k) clearance for its Rosa robotic-assisted total shoulder replacement system, a significant advancement in orthopedic surgery. The system, designed for anatomic or reverse total shoulder replacement, is the latest addition to the company’s Rosa robotics portfolio. The Rosa shoulder system is set to be commercially available in the U.S. in the second half of 2024.
Genetic Variants Linked to Thumb Arthritis Treatment
A new study published in the Journal of Orthopaedic Research has shed light on the genetics of thumb arthritis treatment. Rhizarthrosis, also known as trapeziometacarpal osteoarthritis, is a form of osteoarthritis that affects the thumb, with treatment options ranging from…